Michelle has the responsibility for setting up the new laboratory for Dr Leopold Parts. Initially, the laboratory will be focused on performing lentiviral-based CRISPR/Cas9 genome-wide screens in human cell lines with subsequent image-based phenotyping of cellular traits. The aim of the research is to interrogate changes in cellular phenotype, particularly in relation to survival after drug treatment or in diverse genetic backgrounds.